This suggests that passive immunization with tau antibodies can be a feasible therapeutic focus on and the CSF degree of p-tau262/356 or with the microtubule binding area (MTBD) can serve as a beneficial biomarker of tau pathology to observe tau therapeutics in scientific trials.A docking station can expand your connectivity alternatives, allowing